Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

MAXAIR

PIRBUTEROL ACETATE

Standard Dose
EQ 0.2MG BASE/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MAXAIR is listed in Drugs@FDA under application 019009 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PIRBUTEROL ACETATE Form and strength AEROSOL, METERED;INHALATION - EQ 0.2MG BASE/INH Sponsor BAUSCH Submission history Latest submission status date: 2001-08-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview MAXAIR is listed in Drugs@FDA under application 019009 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PIRBUTEROL ACETATE Form and strength AEROSOL, METERED;INHALATION - EQ 0.2MG BASE/INH Sponsor BAUSCH Submission history Latest submission status date: 2001-08-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.